Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

GNPS - Drug metabolism by gut community

ABSTRACT: Bacterial community culture with drugs acquired on Exploris 240 with chromatographic separation on a Phenomenex polar C18 column (Kinetex 2.6 um, 100 x 2.1 mm). Reversed-phase, ESI positive.

INSTRUMENT(S): Orbitrap Exploris 240

ORGANISM(S): Bacteria (ncbitaxon:2)

SUBMITTER: Pieter C. Dorrestein

PROVIDER: MSV000096589 | GNPS | Wed Dec 04 08:58:00 GMT 2024

REPOSITORIES: GNPS

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Drug metabolism - Bacterial synthetic community

Project description:Bacterial culture with drugs acquired on Q Exactive with chromatographic separation on a Phenomenex polar C18 column (Kinetex 2.6 um, 150 x 2.1 mm). Reversed-phase, ESI positive.

2024-07-14 | MSV000095331 | MassIVE

GNPS - Drug metabolism - Bacterial synthetic community

2024-07-14 | MSV000095331 | GNPS

Consistency across multi-omics layers in a drug-perturbed gut microbial community

Project description:Here we map the molecular response of a synthetic community of 32 human gut bacteria to three non-antibiotic drugs by using five omics layers, namely 16S rRNA gene profiling, metagenomics, metatranscriptomics, metaproteomics, and metabolomics. Using this controlled setting, we find that all omics methods with species resolution in their readouts are highly consistent in estimating relative species abundances across conditions. Furthermore, different omics methods can be complementary in their ability to capture functional changes in response to the drug perturbations. For example, while nearly all omics data types captured that the antipsychotic drug chlorpromazine selectively inhibits Bacteroidota representatives in the community, the metatranscriptome and metaproteome suggested that the drug induces stress responses related to protein quality control and metabolomics revealed a decrease in polysaccharide uptake, likely caused by Bacteroidota depletion. Taken together, our study provides insights into how multi-omics datasets can be utilised to reveal complex molecular responses to external perturbations in microbial communities.

2022-12-13 | PXD036445 | Pride

20231123_ChemProp2_Non-targeted Metabolomics of Xenobiotic Biotransformations using synthetic gut bacterial community

Project description:ChemProp2 Dataset: Investigating potential biotransformations with a panel of 45 Drugs on Synthetic Community (Com20) to elucidate Drug-Microbiome-Host Dynamics

2023-12-05 | MSV000093571 | MassIVE

20240530_ChemProp2_Non-targeted Metabolomics of Xenobiotic Biotransformations using synthetic gut bacterial community

Project description:ChemProp2 Dataset: Investigating potential biotransformations with a panel of 12 Drugs on Synthetic Community (Com20) for 9 timepoints (t0 - t8) to elucidate Drug-Microbiome-Host Dynamics

2024-05-30 | MSV000094899 | MassIVE

16S rRNA community profiling of the gut of the African Palm weevil

Project description:To explore the bacterial community profile of the gut of the African palm weevil and to identify the abundance and diversity of lignin degradation-associated bacteria in each gut segment.

2025-01-01 | E-MTAB-13719 | biostudies-arrayexpress

GNPS - Siderophore in fresh water microbial community

Project description:Investigating siderophore presence in fresh water microbial community. Untargeted LC-MS/MS acquisition was performed on a Vanquish Flex UHPLC system coupled to an Orbitrap Exploris 240 (Thermo Fisher Scientific, Bremen, Germany). Chromatographic separation was performed on a Kinetex 1.7 um 100 A pore size C18 reversed phase UHPLC column 100 x 2.1 mm (Phenomenex, Torrance, CA). LC-MS/MS data acquired in positive mode.

2025-01-17 | MSV000096888 | GNPS

Spatial transcriptome uncovers rich coordination of metabolism and signaling in bacterial community (data 2)

Project description:Spatial transcriptome uncovers rich coordination of metabolism and signaling in bacterial community (data 2)

2023-03-01 | GSE213531 | GEO

Consistency across multi-omics layers in a drug-perturbed gut microbial community

Project description:Multi-omics analyses are increasingly employed in microbiome studies to obtain a holistic view of molecular changes occurring within microbial communities exposed to different conditions. However, it is not always clear to what extent each omics data type contributes to our understanding of the community dynamics and whether they are concordant with each other. Here we map the molecular response of a synthetic community of 32 human gut bacteria to three non-antibiotic drugs by using five omics layers, namely 16S rRNA gene profiling, metagenomics, metatranscriptomics, metaproteomics, and metabolomics. Using this controlled setting, we find that all omics methods with species resolution in their readouts are highly consistent in estimating relative species abundances across conditions. Furthermore, different omics methods complement each other in their ability to capture functional changes in response to the drug perturbations. For example, while nearly all omics data types captured that the antipsychotic drug chlorpromazine selectively inhibits Bacteroidota representatives in the community, the metatranscriptome and metaproteome suggested that the drug induces stress responses related to protein quality control and metabolomics revealed a decrease in polysaccharide uptake, likely caused by Bacteroidota depletion. Taken together, our study provides insights into how multi-omics datasets can be utilised to reveal complex molecular responses to external perturbations in microbial communities.

2022-12-08 | MTBLS3129 | MetaboLights

GNPS Drug metabolism by the human gut microbiome

Project description:Ex vivo communities derived from human microbiome samples incubated with a range of drugs.

2019-12-02 | MSV000084641 | GNPS